{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:44:18Z","timestamp":1791819858344,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.phrs.2022.106345","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:21:16Z","timestamp":1657246876000},"page":"106345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"182","author":[{"given":"Ziwei","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.phrs.2022.106345_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J. Card. Fail"},{"issue":"2","key":"10.1016\/j.phrs.2022.106345_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tcb.2006.12.003","article-title":"Iron uptake and metabolism in the new millennium","volume":"17","author":"Dunn","year":"2007","journal-title":"Trends Cell Biol."},{"issue":"2S\u20132","key":"10.1016\/j.phrs.2022.106345_bib3","doi-asserted-by":"crossref","first-page":"676S","DOI":"10.1093\/jn\/131.2.676S","article-title":"Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship","volume":"131","author":"Haas","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2022.106345_bib4","doi-asserted-by":"crossref","unstructured":"Andrews N.C. Disorders of iron metabolism. N Engl J Med. 1999 Dec 23;341(26):1986\u201395. doi: 10.1056\/NEJM199912233412607. Erratum in: N Engl J Med 2000 Feb 3;342(5):364. PMID: 10607817.","DOI":"10.1056\/NEJM199912233412607"},{"key":"10.1016\/j.phrs.2022.106345_bib5","doi-asserted-by":"crossref","unstructured":"Jankowska E.A., Rozentryt P., Witkowska A., Nowak J., Hartmann O., Ponikowska B., et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010 Aug;31(15):1872\u201380. doi: 10.1093\/eurheartj\/ehq158. Epub 2010 Jun 21. Erratum in: Eur Heart J. 2011 May;32(9):1054. PMID: 20570952.","DOI":"10.1093\/eurheartj\/ehr115"},{"key":"10.1016\/j.phrs.2022.106345_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","author":"Klip","year":"2013","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.phrs.2022.106345_bib7","first-page":"151","article-title":"The efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a systematic review and meta-analysis","volume":"32","author":"Qian","year":"2016","journal-title":"Can. J. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106345_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur. J. Heart Fail"},{"issue":"8","key":"10.1016\/j.phrs.2022.106345_bib9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials","volume":"110","author":"Graham","year":"2021","journal-title":"Clin. Res Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106345_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106345_bib11","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ehf2.12797","article-title":"Anaemia, iron deficiency and heart failure in 2020: facts and numbers","volume":"7","author":"Chopra","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.phrs.2022.106345_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.phrs.2022.106345_bib13","unstructured":"McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., B\u00f6hm M., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599\u20133726. doi: 10.1093\/eurheartj\/ehab368. Erratum in: Eur Heart J. 2021 Oct 14: PMID: 34447992."},{"issue":"4","key":"10.1016\/j.phrs.2022.106345_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfs017","article-title":"Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis","volume":"14","author":"Avni","year":"2012","journal-title":"Eur. J. Heart Fail"},{"issue":"1","key":"10.1016\/j.phrs.2022.106345_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur. J. Heart Fail"},{"issue":"3","key":"10.1016\/j.phrs.2022.106345_bib16","first-page":"1","article-title":"Indirect comparison between ferric carboxymaltose and oral iron replacement in heart failure with reduced ejection fraction: a network meta-analysis","volume":"91","author":"Sciatti","year":"2021","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"2","key":"10.1016\/j.phrs.2022.106345_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth. Methods"},{"issue":"2","key":"10.1016\/j.phrs.2022.106345_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Res Synth. Methods"},{"issue":"17","key":"10.1016\/j.phrs.2022.106345_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106345_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106345_bib21","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.phrs.2022.106345_bib22","unstructured":"Ponikowski P., Kirwan B.A., Anker S.D., McDonagh T., Dorobantu M., Drozdz J., et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020 Dec 12;396(10266):1895\u20131904. doi: 10.1016\/S0140\u20136736(20)32339\u20134. Epub 2020 Nov 13. Erratum in: Lancet. 2021 Nov 27;398(10315):1964. PMID: 33197395."},{"key":"10.1016\/j.phrs.2022.106345_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejps.2017.10.021","article-title":"Sucrosomial\u00ae iron absorption studied by in vitro and ex-vivo models","author":"Fabiano","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"10.1016\/j.phrs.2022.106345_bib24","first-page":"2779","article-title":"Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study","volume":"25","author":"Mafodda","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.phrs.2022.106345_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/ph11040097","article-title":"Sucrosomial\u00ae iron: a new generation iron for improving oral supplementation","author":"G\u00f3mez-Ram\u00edrez","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.phrs.2022.106345_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12185-017-2373-3","article-title":"Modern iron replacement therapy: clinical and pathophysiological insights","volume":"107","author":"Girelli","year":"2018","journal-title":"Int J. Hematol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106345_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/njcp.njcp_387_19","article-title":"Iron deficiency anemia in nigerians with heart failure (IDAN-HF): therapeutic efficacy of iron replacement: an interventional study","volume":"24","author":"Akintunde","year":"2021","journal-title":"Niger. J. Clin. Pr."},{"issue":"1","key":"10.1016\/j.phrs.2022.106345_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurheartj\/ehr504","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study","volume":"34","author":"Comin-Colet","year":"2013","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.phrs.2022.106345_bib29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","article-title":"Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial","volume":"15","author":"Filippatos","year":"2013","journal-title":"Eur. J. Heart Fail."},{"issue":"21","key":"10.1016\/j.phrs.2022.106345_bib30","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency","volume":"139","author":"Charles-Edwards","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2022.106345_bib31","doi-asserted-by":"crossref","unstructured":"Lewis G.D., Malhotra R., Hernandez A.F., McNulty S.E., Smith A., Felker G.M., et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017 May 16;317(19):1958\u20131966. doi: 10.1001\/jama.2017.5427. Erratum in: JAMA. 2017 Jun 20;317(23):2453. PMID: 28510680; PMCID: PMC5703044.","DOI":"10.1001\/jama.2017.5427"},{"key":"10.1016\/j.phrs.2022.106345_bib32","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.ijcard.2013.06.045","article-title":"Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis","author":"Gutzwiller","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106345_bib33","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1177\/0300060519847352","article-title":"Effects of 6-months of oral ferrous and ferric supplement therapy in patients who were hospitalized for decompensated chronic heart failure","volume":"47","author":"Zdravkovic","year":"2019","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106345_bib34","first-page":"344","article-title":"Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC","volume":"5","author":"Yeo","year":"2018","journal-title":"Heart Fail."},{"issue":"48","key":"10.1016\/j.phrs.2022.106345_bib35","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1093\/eurheartj\/ehab411","article-title":"The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial","volume":"42","author":"Martens","year":"2021","journal-title":"Eur. Heart J."},{"issue":"31","key":"10.1016\/j.phrs.2022.106345_bib36","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/eurheartj\/ehab234","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study","volume":"42","author":"Jankowska","year":"2021","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.phrs.2022.106345_bib37","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:41:26Z","timestamp":1760913686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"alternative-id":["S1043661822002900"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106345","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106345"}}